SK284641B6 - Soľ s priaznivými organoleptickými vlastnosťami, spôsob jej prípravy a farmaceutický prostriedok, ktorý ju obsahuje - Google Patents
Soľ s priaznivými organoleptickými vlastnosťami, spôsob jej prípravy a farmaceutický prostriedok, ktorý ju obsahuje Download PDFInfo
- Publication number
- SK284641B6 SK284641B6 SK107-2000A SK1072000A SK284641B6 SK 284641 B6 SK284641 B6 SK 284641B6 SK 1072000 A SK1072000 A SK 1072000A SK 284641 B6 SK284641 B6 SK 284641B6
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- salt
- solvates
- anion
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Seasonings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9701293A HUP9701293A3 (en) | 1997-07-25 | 1997-07-25 | New salts without unsavoury taste and pharmaceutical compositions containing them |
| PCT/HU1998/000066 WO1999004822A2 (fr) | 1997-07-25 | 1998-07-22 | Sels a proprietes organoleptiques benefiques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK1072000A3 SK1072000A3 (en) | 2000-11-07 |
| SK284641B6 true SK284641B6 (sk) | 2005-08-04 |
Family
ID=89995415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK107-2000A SK284641B6 (sk) | 1997-07-25 | 1998-07-22 | Soľ s priaznivými organoleptickými vlastnosťami, spôsob jej prípravy a farmaceutický prostriedok, ktorý ju obsahuje |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1003557B1 (fr) |
| AR (1) | AR016540A1 (fr) |
| AU (1) | AU8553598A (fr) |
| EA (1) | EA002719B1 (fr) |
| EE (1) | EE04098B1 (fr) |
| GE (1) | GEP20022613B (fr) |
| HR (1) | HRP20000037A2 (fr) |
| HU (1) | HUP9701293A3 (fr) |
| PL (1) | PL344038A1 (fr) |
| SK (1) | SK284641B6 (fr) |
| TW (1) | TW509569B (fr) |
| UA (1) | UA69390C2 (fr) |
| WO (1) | WO1999004822A2 (fr) |
| YU (1) | YU3400A (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10013712A1 (de) * | 2000-03-20 | 2001-09-27 | Nutrinova Gmbh | Nikotinsalze mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung |
| US20020081360A1 (en) * | 2000-12-27 | 2002-06-27 | Andreas Burgard | Salts of L-amino acid having improved taste and their preparation |
| DE10130504B4 (de) | 2001-06-25 | 2005-02-03 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Xanthin- und Phenazon-Acesulfam-H-Komplexe mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung |
| JP2011506374A (ja) * | 2007-12-12 | 2011-03-03 | ウルティモルフィクス・テクノロジーズ・ベー・フェー | テノホビルジソプロキシルの固形物 |
| US7935817B2 (en) * | 2008-03-31 | 2011-05-03 | Apotex Pharmachem Inc. | Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof |
| CN103664781B (zh) * | 2013-12-13 | 2015-12-09 | 浙江普洛康裕制药有限公司 | 盐酸屈他维林晶型i和晶型ii及制备方法 |
| CN103694171B (zh) * | 2013-12-13 | 2016-06-29 | 浙江普洛康裕制药有限公司 | 盐酸屈他维林晶型iii和晶型iv及其制备方法 |
| EP4561531A1 (fr) * | 2022-07-29 | 2025-06-04 | Drotastar LLC | Formulation pharmaceutique liquide orale stable d'un agent antispasmodique |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE621917A (fr) * | ||||
| GB1577196A (en) * | 1977-06-03 | 1980-10-22 | Ile De France | Compositions containing erythromycin and metoclopramide |
| FR2633181B1 (fr) * | 1988-06-24 | 1992-01-10 | Glaxo Lab Sa | Composition pharmaceutique a base de ranitidine et son procede de preparation |
| BE1002406A5 (fr) * | 1988-09-20 | 1991-01-29 | Glaxo Group Ltd | Compositions pharmaceutiques. |
-
1997
- 1997-07-25 HU HU9701293A patent/HUP9701293A3/hu unknown
-
1998
- 1998-07-14 TW TW087111464A patent/TW509569B/zh active
- 1998-07-22 PL PL98344038A patent/PL344038A1/xx not_active IP Right Cessation
- 1998-07-22 GE GEAP19985234A patent/GEP20022613B/en unknown
- 1998-07-22 HR HR20000037A patent/HRP20000037A2/hr not_active Application Discontinuation
- 1998-07-22 WO PCT/HU1998/000066 patent/WO1999004822A2/fr not_active Ceased
- 1998-07-22 EE EEP200000049A patent/EE04098B1/xx not_active IP Right Cessation
- 1998-07-22 EP EP98936573A patent/EP1003557B1/fr not_active Expired - Lifetime
- 1998-07-22 EA EA200000160A patent/EA002719B1/ru not_active IP Right Cessation
- 1998-07-22 AU AU85535/98A patent/AU8553598A/en not_active Abandoned
- 1998-07-22 YU YU3400A patent/YU3400A/sh unknown
- 1998-07-22 SK SK107-2000A patent/SK284641B6/sk unknown
- 1998-07-22 UA UA2000021067A patent/UA69390C2/uk unknown
- 1998-07-24 AR ARP980103653A patent/AR016540A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU8553598A (en) | 1999-02-16 |
| YU3400A (sh) | 2002-03-18 |
| HUP9701293A2 (hu) | 1999-02-01 |
| HU9701293D0 (en) | 1997-09-29 |
| AR016540A1 (es) | 2001-07-25 |
| TW509569B (en) | 2002-11-11 |
| SK1072000A3 (en) | 2000-11-07 |
| EA200000160A1 (ru) | 2000-10-30 |
| EE04098B1 (et) | 2003-08-15 |
| EE200000049A (et) | 2000-10-16 |
| EP1003557B1 (fr) | 2003-05-02 |
| EA002719B1 (ru) | 2002-08-29 |
| GEP20022613B (en) | 2002-01-25 |
| HRP20000037A2 (en) | 2000-10-31 |
| EP1003557A2 (fr) | 2000-05-31 |
| HUP9701293A3 (en) | 1999-08-30 |
| UA69390C2 (uk) | 2004-09-15 |
| PL344038A1 (en) | 2001-09-24 |
| WO1999004822A3 (fr) | 1999-08-12 |
| WO1999004822A2 (fr) | 1999-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4160827A (en) | Metronidazole phosphate and salts | |
| IL148406A (en) | Tramadol salts for pharmaceutical use | |
| CH644105A5 (fr) | Acides et esters 4-amino-3-quinoleinecarboxyliques, utiles notamment comme agent antisecretoires et anti-ulcere. | |
| JPS5923313B2 (ja) | （＋）カテキンの水溶性複塩およびその製造方法 | |
| ES2264210T3 (es) | Derivados de xantina para el tratamiento de la isquemia cerebral. | |
| US20150353467A1 (en) | 3,4-diaminopyridine tartrate and phosphate, pharmaceutical compositions and uses thereof | |
| EP0430201B1 (fr) | Aminocarbonylcarbamates apparentés à la physostigmine, leur procédé de préparation et leur utilisation comme médicaments | |
| JPH0825879B2 (ja) | 抗うつまたは抗パーキンソン病薬 | |
| SK284641B6 (sk) | Soľ s priaznivými organoleptickými vlastnosťami, spôsob jej prípravy a farmaceutický prostriedok, ktorý ju obsahuje | |
| US7786168B2 (en) | Phenolic acid salts of gabapentin in solid dosage forms and methods of use | |
| PT93571B (pt) | Processo para a preparacao do acido (s)-7-(3-amino-1-pirrolidinil)-1-ciclopropil -6-fluoro-1,4-dihidro-4-oxo-1,8-naftiridino-3-carboxilico e de composicoes farmaceuticas que o contem | |
| US12134617B1 (en) | Pyrimido[1′6′:1,5]pyrazolo[4,3-c][1,7]naphthyridines as CK2 inhibitors | |
| CS209858B2 (en) | Method of making the new derivatives of the aminoacids | |
| EP1628656B1 (fr) | Tannate de gabapentine sous une forme galenique liquide ou semi-solide | |
| CZ2000289A3 (cs) | Sůl s příznivými organoleptickými vlastnostmi, způsob její přípravy a farmaceutický prostředek, který ji obsahuje | |
| US20050069584A1 (en) | Diphenhydramine tannate solid dose compositions and methods of use | |
| US7115655B2 (en) | Pyranocoumarin derivatives | |
| US4198414A (en) | Compounds and methods for treating diabetic complications | |
| JPH11505240A (ja) | 減量用薬剤 | |
| BG64643B1 (bg) | Нови соли с полезни органолептични свойства | |
| EP0104053A1 (fr) | Benzodiazépines pour le traitement de troubles paniques | |
| US4075408A (en) | Imidazopyrazolodiazepine compounds | |
| US12269827B1 (en) | Substituted pyrazino[1′,2′:1,5]pyrazolo[4,3-c][1,6]naphthyridines as CK2 inhibitors | |
| JPH07255419A (ja) | （＋）カテキンを配合した健康食品および医薬品 | |
| US4151282A (en) | Compositions and methods for treating diabetic complications |